Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador ; volume:17 ; number:1 ; day:29 ; month:7 ; year:2020 ; pages:1-5 ; date:12.2020
AIDS research and therapy ; 17, Heft 1 (29.7.2020), 1-5, 12.2020
- Urheber
-
Checa, Alejandro
Castillo, Alberto
Camacho, Malena
Tapia, William
Hernandez, Isabel
Teran, Enrique
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-020-00303-1
- URN
-
urn:nbn:de:101:1-2020092523341373559264
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Checa, Alejandro
- Castillo, Alberto
- Camacho, Malena
- Tapia, William
- Hernandez, Isabel
- Teran, Enrique
- SpringerLink (Online service)
Ähnliche Objekte (12)
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
Lopinavir- und Efavirenz-Serumkonzentrationen bei antiretroviral behandelten HIV-infizierten Kindern in Südafrika
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
Lopinavir- und Efavirenz-Serumkonzentrationen bei antiretroviral behandelten HIV-infizierten Kindern in Südafrika
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
Lopinavir- und Efavirenz-Serumkonzentrationen bei antiretroviral behandelten HIV-infizierten Kindern in Südafrika
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Development of Efavirenz nanoparticle for enhanced efficiency of anti-retroviral therapy against HIV and AIDS
Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz